Inhibition of apoptosis facilitates necrosis induced by cisplatin in gastric cancer cells

Anti-Cancer Drugs

Volumn 19, Issue 2, 2008, Pages 159-166

  Zhang, Lin Jie ^a   Hao, Yuan Zhang ^a   Hu, Chun Song ^a   Ye, Yan ^a   Xie, Qi Peng ^a   Thorne, Rick F ^b   Hersey, Peter ^c   Zhang, Xu Dong ^a,c,d  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c CALVARY MATER NEWCASTLE HOSPITAL   (Australia)

^d David Maddison Clinical Sciences Building ^*  (Australia)

Author keywords

Apoptosis; Cisplatin; Gastric cancer; Necrosis; Noxa

Indexed keywords

CASPASE; CISPLATIN; DNA FRAGMENT; SMALL INTERFERING RNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CELL; CELL DEATH; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STOMACH CANCER; UPREGULATION;

ADENOSINE TRIPHOSPHATE; AMINO ACID CHLOROMETHYL KETONES; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; BUTYLATED HYDROXYTOLUENE; CASPASE 3; CASPASES; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; CYSTEINE PROTEINASE INHIBITORS; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; HUMANS; INTRACELLULAR FLUID; MICROSCOPY, ELECTRON, TRANSMISSION; NECROSIS; PHOSPHATIDYLSERINES; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, SMALL INTERFERING; STOMACH NEOPLASMS; TRANSFECTION;

EID: 37849052807     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e3282f30d05     Document Type: Article

References (21)

1. Edinger L, Thompson CB. Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol 2004; 16:663-669.
2. Adams JM. Ways of dying: multiple pathways to apoptosis. Genes Dev 2003; 17:2481-2495.
3. Majno G, Joris I. Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995; 146:3-15.
4. Hersey P, Zhang XD. Overcoming resistance of cancer cells to apoptosis. J Cell Physiol 2003; 196:9-18.
5. Soengas MS, Lowe SW. Apoptosis and melanoma chemoresistance. Oncogene 2003; 22:3138-3151.
6. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 1998; 281:1322-1326.
7. Shimizu S, Narita M, Tsujimoto Y. Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 1999; 399:483-487.
8. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev 2004; 18:1272-1282.
9. Gillespie SK, Zhang XD, Hersey P. Ingenol 3-angelate induces dual modes of cell death and differentially regulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in melanoma cells. Mol Cancer Ther 2004; 3:1651-1658.
10. Jiang CC, Chen LH, Gillespie S, Kiejda KA, Mhaidat N, Wang YF, et al. Tunicamycin sensitizes human melanoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by up-regulation of TRAIL-R2 via the unfolded protein response. Cancer Res 2007; 67: 5880-5888.
11. Zhang XD, Wu JJ, Gillespie S, Borrow J, Hersey P. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Clin Cancer Res 2006; 12: 1355-1364.
12. Walsh GM, Dewson G, Wardlaw AJ, Levi-Schaffer F, Moqbel R. A comparative study of different methods for the assessment of apoptosis and necrosis in human eosinophils. J Immunol Methods 1998; 217:153-163.
13. Gonzalez VM, Fuertes MA, Alonso C, Perez JM. Is cisplatin-induced cell death always produced by apoptosis? Mol Pharmacol 2001; 59:657-663.
14. Roos WP, Kaina B. DNA damage-induced cell death by apoptosis. Trends Mol Med 2006; 12:440-450.
15. Martinou JC, Green DR. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol 2001; 2:63-67.
16. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, et al. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 2005; 17:393-403.
17. Fenoglio-Preiser CM, Wang J, Stemmermann GN, Noffsinger A. TP53 and gastric carcinoma: a review. Hum Mutat 2003; 21:258-270.
18. Ferrer M, Izeboud T, Ferreira CG, Span SW, Giaccone G, Kruyt FA. Cisplatin triggers apoptotic or nonapoptotic cell death in Fanconi anemia lymphoblasts in a concentration-dependent manner. Exp Cell Res 2003; 286:381-395.
19. Shibuya H, Kato Y, Saito M, Isobe T, Tsuboi R, Koga M, et al. Induction of apoptosis and/or necrosis following exposure to antitumour agents in a melanoma cell line, probably through modulation of Bcl-2 family proteins. Melanoma Res 2003; 13:457-464.
20. Leist M, Jaattela M. Four deaths and a funeral: from caspases to alternative mechanisms. Nat Rev Mo Cell Biol 2001; 2:589-598.
21. Hersey P, Zhang XD. Current strategies in overcoming resistance of cancer cells to apoptosis melanoma as a model. Int Rev Cytol 2006; 251:131-158.